Ikarian Capital, LLC Arvinas, Inc. Put Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$20.19 - $84.93 $1.09 Million - $4.59 Million
-54,000 Reduced 35.06%
100,000 $8.49 Million
Q2 2020

Aug 14, 2020
BUY
$29.88 - $56.74 $4.51 Million - $8.56 Million
150,900 Added 4867.74%
154,000 $5.17 Million
Q4 2019

Jan 31, 2020
BUY
$15.39 - $44.38 $47,709 - $137,578
3,100 New
3,100 $127,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.42B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email